I was watching your commentary and you were right all along -...

I was watching your commentary and you were right all along - and boy did you come up against it in these threads!

A company with unknown technology reliant largely on telehealth which has negligible uptake within the community reletively speaking, with a $300M valuation? I think it will come down further when people come to realise just how far out the commercial viability of this product is, if even possible at all.

I had a mate who is a respiratory physician and researcher review RAPs grant applications about 6 months ago and he wrote back to me one word... "avoid". The design methodologies were apparently highly flawed - and he also had concerns about differential diagnosis.

RAP should consider themselves foruntate to have a market cap of even $5M imo! An 'idea' isn't worth shit without $$ coming in the door. And the directors of this company were shockers - some of the official announcements were effectively just propaganda - and then they solds shares.

So many retails investors got burnt here and will never make it back. They are wiped out for life.